相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake
Xiaoxiao Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Progesterone action in breast, uterine, and ovarian cancers
Caroline H. Diep et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Activation of Liver X Receptor Induces Macrophage Interleukin-5 Expression
Yuanli Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The macrophage pattern recognition scavenger receptors SR-A and CD36 protect against microbial induced pregnancy loss
Helieh S. Oz et al.
INFLAMMATION RESEARCH (2011)
Increased CD36 Expression Signals Monocyte Activation Among Patients With Type 2 Diabetes
Yijuan Sun et al.
DIABETES CARE (2010)
Soluble CD36 (sCD36) Clusters with Markers of Insulin Resistance, and High sCD36 Is Associated with Increased Type 2 Diabetes Risk
A. Handberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease
Jan F. C. Glatz et al.
PHYSIOLOGICAL REVIEWS (2010)
Gene expression in human NAFLD
Dario Greco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol
Latisha Love-Gregory et al.
HUMAN MOLECULAR GENETICS (2008)
Peroxisome proliferator-activated receptor γ is a target of progesterone regulation in the preovulatory follicles and controls ovulation in mice
Jaeyeon Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma - A novel marker of insulin resistance
Aase Handberg et al.
CIRCULATION (2006)
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
S. Ohidar Rahaman et al.
CELL METABOLISM (2006)
Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance
E. Corpeleijn et al.
DIABETIC MEDICINE (2006)
Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition
P. Froment et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Estrogen receptor-α mediates gender differences in atherosclerosis induced by HIV protease inhibitors
KF Allred et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function
K Wassmann et al.
CIRCULATION RESEARCH (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36
JH Han et al.
CIRCULATION (2004)
Estrogen plus progestin and the risk of peripheral arterial disease - The Women's Health Initiative
J Hsia et al.
CIRCULATION (2004)
Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis
M Febbraio et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials?
KK Koh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line
L Sun et al.
JOURNAL OF LIPID RESEARCH (2003)
Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women
HN Hodis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cytokine milieu tends toward inflammation in type 2 diabetes
K Esposito et al.
DIABETES CARE (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice
T Hajri et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period
CM Komar et al.
ENDOCRINOLOGY (2001)
Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats
M Pravenec et al.
NATURE GENETICS (2001)
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
DM Herrington et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
M Febbraio et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Transforming growth factor-β1 (TGF-β1) and TGF-β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-γ
JH Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)